ID

36603

Descripción

High Dose Versus Routine Dose Icotinib in Advanced Non-small Cell Lung Cancer Patients With Stable Disease; ODM derived from: https://clinicaltrials.gov/show/NCT02027090

Link

https://clinicaltrials.gov/show/NCT02027090

Palabras clave

Versiones (1)
  1. 26/5/19 26/5/19 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

26 de mayo de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Non-small Cell Lung Cancer NCT02027090

Inglés

Eligibility Non-small Cell Lung Cancer NCT02027090

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically or cytologically confirmed stage iiib/iv lung cancer(exclude patients confirmed by sputum cytology);
Descripción

Carcinoma of lung TNM clinical staging | Sputum Cytology Excluded

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0684249
UMLS CUI [1,2]
C3258246
UMLS CUI [2,1]
C1521752
UMLS CUI [2,2]
C0332196
pretreated with at least 1 platinum-based chemotherapy;
Descripción

Pretreatment Chemotherapy Platinum-Based

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3539076
UMLS CUI [1,2]
C0392920
UMLS CUI [1,3]
C1514162
no previous targeted treatment such as gefitinib, erlotinib;
Descripción

Targeted Therapy Absent | Gefitinib Absent | Erlotinib Absent

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2985566
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C1122962
UMLS CUI [2,2]
C0332197
UMLS CUI [3,1]
C1135135
UMLS CUI [3,2]
C0332197
with a measurable disease(longest diameters >=10mm with spiral computed tomography (ct)and >=20mm with conventional ct) according to recist criteria;
Descripción

Measurable Disease | Longest Diameter Spiral CT | Longest Diameter CT

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1513041
UMLS CUI [2,1]
C0552406
UMLS CUI [2,2]
C0860888
UMLS CUI [3,1]
C0552406
UMLS CUI [3,2]
C0040405
who performance status(ps)<= 2;
Descripción

WHO performance status scale

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1298650
adequate organ functions;
Descripción

Organ function

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0678852
signed and dated informed consent before the start of specific protocol procedures.
Descripción

Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
allergic to icotinib;
Descripción

Hypersensitivity Icotinib

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C2604307
patients with metastatic brain tumors with symptoms;
Descripción

Symptoms Metastatic malignant neoplasm to brain

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1457887
UMLS CUI [1,2]
C0220650
experience of anti-egfr(the epidermal growth factor receptor) monoclonal antibody or small molecular compounds therapy such as gefitinib, erlotinib or cetuximab;
Descripción

Anti-EGFR Monoclonal Antibody | Small Molecule Compound Therapy | gefitinib | erlotinib | cetuximab

Tipo de datos

boolean

Alias
UMLS CUI [1]
C4522190
UMLS CUI [2,1]
C1328819
UMLS CUI [2,2]
C1706082
UMLS CUI [2,3]
C0087111
UMLS CUI [3]
C1122962
UMLS CUI [4]
C1135135
UMLS CUI [5]
C0995188
severe systemic disease out of control such as unstable or uncompensated respiratory,cardiac,liver,renal diseases.
Descripción

Systemic disease Severe Uncontrolled | Respiration Disorder Unstable | Heart Disease Unstable | Liver disease Unstable | Kidney Disease Unstable | Respiration Disorder Uncompensated | Heart Disease Uncompensated | Liver disease Uncompensated | Kidney Disease Uncompensated

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0442893
UMLS CUI [1,2]
C0205082
UMLS CUI [1,3]
C0205318
UMLS CUI [2,1]
C0035204
UMLS CUI [2,2]
C0443343
UMLS CUI [3,1]
C0018799
UMLS CUI [3,2]
C0443343
UMLS CUI [4,1]
C0023895
UMLS CUI [4,2]
C0443343
UMLS CUI [5,1]
C0022658
UMLS CUI [5,2]
C0443343
UMLS CUI [6,1]
C0035204
UMLS CUI [6,2]
C0205433
UMLS CUI [7,1]
C0018799
UMLS CUI [7,2]
C0205433
UMLS CUI [8,1]
C0023895
UMLS CUI [8,2]
C0205433
UMLS CUI [9,1]
C0022658
UMLS CUI [9,2]
C0205433
Volver a la parte superior de la página

Similar models

Eligibility Non-small Cell Lung Cancer NCT02027090

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Carcinoma of lung TNM clinical staging | Sputum Cytology Excluded
Item
histologically or cytologically confirmed stage iiib/iv lung cancer(exclude patients confirmed by sputum cytology);
boolean
C0684249 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
C1521752 (UMLS CUI [2,1])
C0332196 (UMLS CUI [2,2])
Pretreatment Chemotherapy Platinum-Based
Item
pretreated with at least 1 platinum-based chemotherapy;
boolean
C3539076 (UMLS CUI [1,1])
C0392920 (UMLS CUI [1,2])
C1514162 (UMLS CUI [1,3])
Targeted Therapy Absent | Gefitinib Absent | Erlotinib Absent
Item
no previous targeted treatment such as gefitinib, erlotinib;
boolean
C2985566 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C1122962 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C1135135 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
Measurable Disease | Longest Diameter Spiral CT | Longest Diameter CT
Item
with a measurable disease(longest diameters >=10mm with spiral computed tomography (ct)and >=20mm with conventional ct) according to recist criteria;
boolean
C1513041 (UMLS CUI [1])
C0552406 (UMLS CUI [2,1])
C0860888 (UMLS CUI [2,2])
C0552406 (UMLS CUI [3,1])
C0040405 (UMLS CUI [3,2])
WHO performance status scale
Item
who performance status(ps)<= 2;
boolean
C1298650 (UMLS CUI [1])
Organ function
Item
adequate organ functions;
boolean
C0678852 (UMLS CUI [1])
Informed Consent
Item
signed and dated informed consent before the start of specific protocol procedures.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Hypersensitivity Icotinib
Item
allergic to icotinib;
boolean
C0020517 (UMLS CUI [1,1])
C2604307 (UMLS CUI [1,2])
Symptoms Metastatic malignant neoplasm to brain
Item
patients with metastatic brain tumors with symptoms;
boolean
C1457887 (UMLS CUI [1,1])
C0220650 (UMLS CUI [1,2])
Anti-EGFR Monoclonal Antibody | Small Molecule Compound Therapy | gefitinib | erlotinib | cetuximab
Item
experience of anti-egfr(the epidermal growth factor receptor) monoclonal antibody or small molecular compounds therapy such as gefitinib, erlotinib or cetuximab;
boolean
C4522190 (UMLS CUI [1])
C1328819 (UMLS CUI [2,1])
C1706082 (UMLS CUI [2,2])
C0087111 (UMLS CUI [2,3])
C1122962 (UMLS CUI [3])
C1135135 (UMLS CUI [4])
C0995188 (UMLS CUI [5])
Systemic disease Severe Uncontrolled | Respiration Disorder Unstable | Heart Disease Unstable | Liver disease Unstable | Kidney Disease Unstable | Respiration Disorder Uncompensated | Heart Disease Uncompensated | Liver disease Uncompensated | Kidney Disease Uncompensated
Item
severe systemic disease out of control such as unstable or uncompensated respiratory,cardiac,liver,renal diseases.
boolean
C0442893 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0205318 (UMLS CUI [1,3])
C0035204 (UMLS CUI [2,1])
C0443343 (UMLS CUI [2,2])
C0018799 (UMLS CUI [3,1])
C0443343 (UMLS CUI [3,2])
C0023895 (UMLS CUI [4,1])
C0443343 (UMLS CUI [4,2])
C0022658 (UMLS CUI [5,1])
C0443343 (UMLS CUI [5,2])
C0035204 (UMLS CUI [6,1])
C0205433 (UMLS CUI [6,2])
C0018799 (UMLS CUI [7,1])
C0205433 (UMLS CUI [7,2])
C0023895 (UMLS CUI [8,1])
C0205433 (UMLS CUI [8,2])
C0022658 (UMLS CUI [9,1])
C0205433 (UMLS CUI [9,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial